Warberg Asset Management’s Pasithea Therapeutics Corp. Warrants KTTAW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-100,000
| Closed | -$2.03K | – | 177 |
|
|
2025
Q1 | $2.03K | Sell |
100,000
-154,701
| -61% | -$3.14K | ﹤0.01% | 158 |
|
|
2024
Q4 | $8.81K | Sell |
254,701
-8,300
| -3% | -$287 | ﹤0.01% | 137 |
|
|
2024
Q3 | $9.18K | Sell |
263,001
-15,683
| -6% | -$547 | ﹤0.01% | 133 |
|
|
2024
Q2 | $4.26K | Sell |
278,684
-11,184
| -4% | -$171 | ﹤0.01% | 161 |
|
|
2024
Q1 | $3.59K | Hold |
289,868
| – | – | ﹤0.01% | 157 |
|
|
2023
Q4 | $5.22K | Hold |
289,868
| – | – | ﹤0.01% | 154 |
|
|
2023
Q3 | $3.8K | Sell |
289,868
-100
| -0% | -$1 | ﹤0.01% | 182 |
|
|
2023
Q2 | $6.23K | Hold |
289,968
| – | – | ﹤0.01% | 157 |
|
|
2023
Q1 | $8.7K | Hold |
289,968
| – | – | ﹤0.01% | 164 |
|
|
2022
Q4 | $9.55K | Sell |
289,968
-20,915
| -7% | -$689 | ﹤0.01% | 177 |
|
|
2022
Q3 | $40K | Sell |
310,883
-300
| -0.1% | -$39 | 0.01% | 149 |
|
|
2022
Q2 | $20K | Buy |
311,183
+11,275
| +4% | +$725 | ﹤0.01% | 153 |
|
|
2022
Q1 | $51K | Buy |
299,908
+80,988
| +37% | +$13.8K | 0.01% | 136 |
|
|
2021
Q4 | $81K | Buy |
+218,920
| New | +$81K | 0.02% | 113 |
|